Ayurveda and pregabalin medicine in diabetic neuropathy treatment
Phase 1
Completed
- Conditions
- Health Condition 1: E104- Type 1 diabetes mellitus with neurological complicationsHealth Condition 2: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2018/12/016598
- Lead Sponsor
- J S AYURVEDA MAHAVIDYALAYA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1)Presence of minimum two symptoms along with moderate impairment, according to NTSS-6 score.
2)Patients of both sex and having the age between 30 to 60 years.
Exclusion Criteria
1)Patients having any other associated clinical conditions influencing peripheral nerve function like peripheral vascular disorders, history of lead toxicity, deficiency and anaemia will be excluded.
2)Patients having any of neuropathic complication i.e. Diabetic foot will be excluded.
3)Patients having chronic alcoholism will be excluded.
4)Patients contraindicated for the pregabalin.
5)Patients with postprandial blood sugar more than 250 mg/dl.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method